10.15.14
Vetter has made several changes within its Development Service Division. Dr. Susanne Resatz, formerly manager Process Development and Manufacturing at the company’s clinical development facility in Chicago, assumes the role of president, taking full responsibility for the site’s operations. Dr. Claudia Roth, formerly in this role, will return to the company’s headquarters in Ravensburg, Germany, where she will head up the newly created “Innovation” department. Both Dr. Resatz and Dr. Roth have been with the U.S. facility since its opening in 2009 and were instrumental in its becoming fully operational in October 2011.
Dr. Resatz’s expertise includes designing and implementing efficient, high-quality manufacturing processes for early-stage products and has experience meeting the requirements of a broad variety of international regulatory authorities.
Dr. Roth will head up the new “Innovation” department in Ravensburg, which will be focused on future customer and product development needs including filling processes and technology, as well as packaging solutions.
“I am thrilled to be in the position to help take Vetter’s Chicago facility to a greater level of customer support,” said Dr. Resatz. “Today, the facility is fully on target from a business perspective, providing our customers with top-of-the-line clinical manufacturing, and proofs that our company’s strategy in taking this step was the right one.”
Also, Dr. Paul Nelles, who headed Vetter´s global Development Service activities in Germany, will take early retirement after 11 years with the company. Dr. Claus Feussner, formerly vice president Quality Control, has assumed this postion effective September 1. Dr. Nelles will continue with his efforts at Vetter until mid-2015 to help with the transition.
“We wish Dr. Resatz and Dr. Roth success in their new positions. In particular, we thank Dr. Roth for her pioneering role in helping to make the Chicago facility a success,” said Thomas Otto, managing director of Vetter. “We eagerly anticipate her return to Ravensburg and her spearheading the important function of the new Innovation department. We also want to thank Dr. Nelles for his many years of service with Vetter and his efforts in the installation and expansion of Vetter’s Development Services activities, and wish Dr. Feussner success in his new role.”
Dr. Resatz’s expertise includes designing and implementing efficient, high-quality manufacturing processes for early-stage products and has experience meeting the requirements of a broad variety of international regulatory authorities.
Dr. Roth will head up the new “Innovation” department in Ravensburg, which will be focused on future customer and product development needs including filling processes and technology, as well as packaging solutions.
“I am thrilled to be in the position to help take Vetter’s Chicago facility to a greater level of customer support,” said Dr. Resatz. “Today, the facility is fully on target from a business perspective, providing our customers with top-of-the-line clinical manufacturing, and proofs that our company’s strategy in taking this step was the right one.”
Also, Dr. Paul Nelles, who headed Vetter´s global Development Service activities in Germany, will take early retirement after 11 years with the company. Dr. Claus Feussner, formerly vice president Quality Control, has assumed this postion effective September 1. Dr. Nelles will continue with his efforts at Vetter until mid-2015 to help with the transition.
“We wish Dr. Resatz and Dr. Roth success in their new positions. In particular, we thank Dr. Roth for her pioneering role in helping to make the Chicago facility a success,” said Thomas Otto, managing director of Vetter. “We eagerly anticipate her return to Ravensburg and her spearheading the important function of the new Innovation department. We also want to thank Dr. Nelles for his many years of service with Vetter and his efforts in the installation and expansion of Vetter’s Development Services activities, and wish Dr. Feussner success in his new role.”